Business
Press Release May 10 2024
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 10, 2024, titled "Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 10, 2024, titled "Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd